Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,079

Document Document Title
WO/2018/128084A1
Provided is a polymerizable compound that has low-wavelength dispersion or reverse-wavelength dispersion, does not readily bubble when made into a coating material, has excellent substrate adhesion when made into a film-like polymer, and...  
WO/2018/116158A1
The present invention relates to new compounds having hydroxyl, imino and carboxylic functionalities, processes for the production thereof and use thereof as antitumour agents for the treatment of solid tumours.  
WO/2018/102427A1
Provided herein are methods of preparation of I by reacting i with acid where R1 and R2 are each independently a leaving group. Intermediates to make i are also claimed.  
WO/2018/088436A1
Disclosed is an ammoximation catalyst useful in producing oximes from ketones with high yield and high selectivity by ammoximation reaction using hydrogen, oxygen and ammonia. The ammoximation catalyst contains (a) a titanosilicate and (...  
WO/2018/085753A1
Provided herein are substituted hydrazone compounds useful as inhibitors of DEPTOR. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted hyd...  
WO/2018/085737A1
Provided herein are compounds for use as photochromic molecular switches having very long thermal isomerization half-lives and switchable fluorescence properties both in solution and the solid state.  
WO/2018/073828A1
Disclosed herein are compounds that are selective DNA primase and/or gyrase inhibitors. Further disclosed are pharmaceutical compositions comprising these compounds, and the uses of these compounds for treating disorders associated with ...  
WO/2018/065997A1
An improved process for the production of concentrated aqueous solutions of hydrazine hydrate by ketazine method is described. In particular, it describes preparation of hydrazine hydrate by ketazine method using 50-70% hydrogen peroxide...  
WO/2018/060959A1
The present disclosure relates to metformin glycinate and methods of using metformin glycinate for the treatment of diseases including diabetes mellitus, obesity, dyslipidemia, diseases associated with IL-10 up-regulation, and diseases o...  
WO/2018/053587A1
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.  
WO/2018/054725A1
The present invention relates to a condensation reaction and/or addition reaction curable coating composition which contains (A) at least one polymer as the binder, (B) at least one crosslinking agent which can be reacted with component ...  
WO/2018/044883A1
Disclosed are silane-functionalized amines useful as curing agents. Examples include the reaction product of: a) aspartate modified polyamine having at least two aspartate amine groups and at least one secondary non-aspartate amino group...  
WO/2018/042871A1
A diazadienyl compound represented by general formula (I). In general formula (I), R1 represents a C1-6 linear or branched alkyl group, and M represents a nickel atom or manganese atom. In particular, a compound in which R1 in general fo...  
WO/2018/033866A1
The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril, inter alia via nitro 5 compounds. It further relates to new intermediate comp...  
WO/2018/021884A1
According to the present invention, a compound represented by chemical formula 1 is characterized by being coordinated with a metal ion, thereby enabling a bidirectional or multi-directional organometallic complex to be formed. Therefore...  
WO/2018/021882A1
According to the present invention, a compound represented by chemical formula 1 is characterized by being coordinated with a metal ion, thereby enabling a bidirectional or multi-directional organometallic complex to be formed. Therefore...  
WO/2018/012459A1
An oxygen separation membrane which is configured of a porous material and a complex in the form of a liquid, said complex being internally contained in the porous material, and wherein: the complex contains a metal salen complex or a de...  
WO/2018/003587A1
Provided are: a method for easily producing, with a high yield, an iron binuclear complex having a structure in which two iron atoms are bonded together through one oxygen atom, and a ligand structure containing a Shiff base, in the mole...  
WO/2017/221586A1
A vanadium compound represented by general formula (1). In general formula (1), R1 represents a linear or branched alkyl group having 1-7 carbon atoms, and preferably represents a secondary alkyl group or a tertiary alkyl group; and n re...  
WO/2017/217553A1
[Problem] To provide a novel agricultural chemical, and particularly an herbicide. [Solution] An oxime compound represented by formula (1) and an herbicide containing the same. (In formula (1): B represents B-1 or the like; Q represents ...  
WO/2017/214680A1
The present invention relates to new multi-functional compounds that are useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease, to the preparation of the compounds, and to compositions including the compounds...  
WO/2017/192691A1
Provided herein is a cell culture medium and methods of using thereof. The cell culture medium generally comprises a compound (e.g., a bromodomain inhibitor) that can enhance product titer, cell viability, cell specific productivity, and...  
WO/2017/169819A1
A black photosensitive resin composition which contains: a photopolymerization initiator composition (A) that contains 1-99 parts by mass of the component (A-1) described below and 1-99 parts by mass of the component (A-2) described belo...  
WO/2017/149640A1
One purpose of the present invention is to provide a liquid crystalline compound which exhibits liquid crystallinity at low temperatures. Another purpose of the present invention is to provide: a thermally responsive material which exhib...  
WO/2017/146581A1
Described are methods for preparing phenols, benzene carboxylic acids, esters and anhydrides thereof from furanic compounds by reaction with a dienophile, wherein the furanic compounds are reacted with a hydrazine and/or oxime and then r...  
WO/2017/133942A1
The present invention relates to a catalytic process for preparing pyrazoles comprising the step of cyclizing hydrazone substituted α,β-unsaturated carbonyl compounds by reacting them with hydrogen in a reaction mixture comprising as c...  
WO/2017/119515A1
An object of the present invention is to provide a novel ascochlorin derivative which activates adenosine monophosphate-activated protein kinase (AMPK), and is useful in the treatment or prevention of diseases or conditions that involve ...  
WO/2017/111176A1
Synthesis of an organic compound with chirality is an important technique in the fields of medicines, pesticides, health foods, etc. However, catalysts to be used for such synthesis are produced from expensive starting materials and, fur...  
WO/2017/102659A1
The invention relates to a method for synthesising at least one nitrogen compound belonging to the family of the partially N-hydroxyethylated tertiary 1,6-hexanediamines of the following general formula (I) in which the groups R1, R2 and...  
WO/2017/105999A1
Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, (Formula 1) wherein Z, Q, R1, R2, R3, R4 and m are as defined in the disclosure. Also disclosed are compositions containing the...  
WO/2017/106520A1
Disclosed are compounds of formulas I and II, in which R, R0, R1-R4, R7-R10, n, X, Y, Y', and E are as described herein, pharmaceutical compositions containing such compounds. The compounds and pharmaceutical compositions are for use in ...  
WO/2017/100644A1
A method of modulating ribonucleotide reductase activity in a neoplastic cell includes administering to the cell an amount of a ribonucleotide reductase modulator (RRmod), the amount being effective to inhibit neoplastic cell growth.  
WO/2017/085747A2
The present invention relates to a novel process for preparation of methyl (αE)-(α- (methoxyimino)-2-[[[(E)-[1-[3- (trifluoromethyl) phenyl] ethylidene] amino] oxy] methyl] benzeneaceate (Trifloxystrobin) compound of formula (I) in fre...  
WO/2017/085747A4
The present invention relates to a novel process for preparation of methyl (αE)-(α- (methoxyimino)-2-[[[(E)-[1-[3- (trifluoromethyl) phenyl] ethylidene] amino] oxy] methyl] benzeneaceate (Trifloxystrobin) compound of formula (I) in fre...  
WO/2017/085747A3
The present invention relates to a novel process for preparation of methyl (αE)-(α- (methoxyimino)-2-[[[(E)-[1-[3- (trifluoromethyl) phenyl] ethylidene] amino] oxy] methyl] benzeneaceate (Trifloxystrobin) compound of formula (I) in fre...  
WO/2017/082144A1
The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt or prodrug thereof. The present invention also provides: a composition which includes the compound represented by formula (I), or...  
WO/2017/076771A1
The present invention relates to selected acylhydrazone compounds, their use as oxidation catalysts and to a process for removing stains and soil on textiles and hard surfaces. The compounds contain two acylhydrazone groups per molecule ...  
WO/2017/067497A3
Disclosed are a monosubstituted or polysubstituted amphiphilic hypocrellin derivative, preparation method therefor, and uses thereof. In the present invention, the amphiphilic hypocrellin derivative having substituted functional groups s...  
WO/2017/067497A9
Disclosed are a monosubstituted or polysubstituted amphiphilic hypocrellin derivative, preparation method therefor, and uses thereof. In the present invention, the amphiphilic hypocrellin derivative having substituted functional groups s...  
WO/2017/068860A1
The present invention provides a compound represented by general formula (I) and a polymerizable composition containing said compound. A polymerizable composition containing a compound represented by general formula (I), when used to pro...  
WO/2017/066421A1
Provided are methods of treating cognitive impairment and/or psychosis and/or movement disorders by administering a pharmaceutical composition of eplivanserin or a pharmaceutically acceptable salt thereof to a subject in need thereof.  
WO/2017/059772A1
Disclosed are a photoinitiator containing a fluorene oxime ester, as shown by the following formula (I), synthesis therefor, a photosensitive resin composition containing same, and a use thereof. The compound is simple in synthesis and l...  
WO/2017/054112A1
The present invention relates to a method of preparing a 3-fluoroalkyl-1-methylpyrazole-4-carboxylic acid comprising the following steps: Step 1, performing a condensation reaction on the fluoroacetyl halide derivative shown in formula I...  
WO/2017/052351A1
The present invention provides: an oxime ester compound, which is suitable for use as a photoinitiator for high-brightness materials and transparent materials and has excellent thermal stability and solubility in an organic solvent; and ...  
WO/2017/043620A1
The present invention relates to a chemical vapor deposition feedstock for manufacturing a ruthenium thin film or ruthenium compound thin film by chemical vapor deposition, the chemical vapor deposition feedstock comprising an organic ru...  
WO/2017/041642A1
Provided is a compound based on a meta-linked bihydrazinoazine structure and a preparation method and a use thereof. The compound can be used as a red probe and has an excellent aggregation-induced luminescence property, and can be used ...  
WO/2017/036436A1
The present invention provides primin derivatives of general formula II and/or III, wherein R1 is selected from the group consisting of methyl and hydrogen, R2 is selected from the group consisting of methoxy, hydroxy, hydrogen, R3 is se...  
WO/2017/040518A1
A method for etching silicon-containing films is disclosed. The method includes the steps of introducing a vapor of a nitrogen containing etching compound into a reaction chamber containing a silicon-containing film on a substrate, where...  
WO/2017/033880A1
An oxime ester compound represented by general formula (I). In general formula (I), at least one of R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 is a group represented by general formula (II). The oxime ester compound preferably contains ...  
WO/2017/024971A1
Provided are an unsaturated oximino ether compound and a use thereof. The compound is as shown by general formula I, wherein the compound of formula I has an excellent bactericidal activity, and especially still has good control effect o...  

Matches 1 - 50 out of 7,079